KRISTINE ASHCRAFT, CEO OF YOUSCRIPT - Preview 1
How has pharmacogenetic testing evolved over the past 20 years? We've moved from a very expensive single-gene testing model focused on drug - gene pairs to a more cost-effective multigene panel approach, which can provide significantly more information. Kristine Ashcraft, CEO of YouScript, which offers a unique combination of pharmacogenetic information and EMR-integrated software, joins us this week on The Personalized Diagnostics Podcast.
